Xcovery pitted its ALK inhibitor against Pfizer’s Xalkori—the first-ever FDA-approved drug in its class—and came out on top. The drug, ensartinib, shrank tumors...
While most children exposed to the novel coronavirus suffer only a mild infection, others may develop a rare but severe reaction that attacks several...
Despite its first overall quarterly sales decline in nearly a decade—dragged down by the global spread of COVID-19, as well as biosimilars encroaching...
The FDA approved a new smartphone app from Abbott allowing people to personalize their own neuromodulation therapies, including regimens for chronic pain and...
A patent court has sided with Arbutus Biopharma in its dispute with Moderna, raising concerns that the intellectual property dispute could stymie COVID-19...
Scientists at Columbia University have identified a cocktail of antibodies they say could be a potent option for treating and preventing COVID-19. The...
